Soluble endoglin for the prediction of preeclampsia in a high risk cohort

Hypertension in Pregnancy

Volumn 29, Issue 3, 2010, Pages 330-341

  Maynard, Sharon E ^a   Moore Simas, Tiffany A ^b   Bur, Lana ^a   Crawford, Sybil L ^b   Solitro, Matthew J ^b   Meyer, Bruce A ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Angiogenic factors; Multiple gestation pregnancy; Preeclampsia; Soluble endoglin

Indexed keywords

CD135 ANTIGEN; ENDOGLIN; PLACENTAL GROWTH FACTOR; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PLACENTA PROTEIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; MULTIPLE PREGNANCY; PLACENTA DEVELOPMENT; PREDICTION; PREECLAMPSIA; SERUM; BLOOD; HIGH RISK PREGNANCY; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY, HIGH-RISK; PREGNANCY, MULTIPLE; RECEPTORS, CELL SURFACE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 77955098116     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950902968684     Document Type: Article

References (18)

1. Maternal mortality-United States, 1982-1996. JAMA 1998;280:1042-1043.
2. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ 2005;330:565.
3. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-683.
4. Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007;197:244 e1-8.
5. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-649 (Pubitemid 43865232)
6. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:992-1005.
7. Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007;50:137-172.
8. Robinson CJ, Johnson DD. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol 2007;197:174 e1-5.
9. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-658.
10. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American college of obstetricians and gynecologists. Int J Gynaecol Obstet 2002;77:67-75.
11. Alexander GR, Kogan M, Martin J, Papiernik E. What are the fetal growth patterns of singletons, twins, and triplets in the United States? Clin Obstet Gynecol 1998;41:114-125.
12. ACOG committee opinion no. 402: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2008;111:805-807.
13. Diggle P, Liang K-Y, Zeger S. Analysis of longitudinal data. Oxford, England: Clarendon Press, 1994.
14. Maynard SE, Moore Simas TA, Solitro MJ, et al. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies. Amer J Obstet Gynecol 2008;198: 200.e1-200.e7.
15. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 2007;196:239 e1-6.
16. Lindheimer MD, Umans JG. Explaining and predicting preeclampsia. N Engl J Med 2006;355:1056-1058.
17. Bdolah Y, Lam C, Rajakumar A, et al. Twin pregnancy and the risk of preeclampsia: Bigger placenta or relative ischemia? Am J Obstet Gynecol 2008;198: 428 e1-6.
18. Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008;111:1403-1409